Saturday, October 15, 2016 8:10:34 PM
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On October 3, 2016, Paul Rosenberg, the Founder and Director of the Corporation, resigned as a member of the Board of Directors. The resignation of Mr. Paul Rosenberg was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. As his final act, Mr. Rosenberg hereby appoints Andrey Soloviev as the sole Director of the Corporation.
Mr. Soloviev is a performance driven seasoned Health Care Executive and Entrepreneur. Having earned his Bachelor of Science degree in 2001 from Touro University in New York, Andrey has more than 15 years of notable success executing strategic healthcare projects. He is an expert in management of health services operations, planning, execution, and regulatory compliance.
IF YOU "CLAIM" SOMETHING TO ME, "PROVE IT" WITH "DOCUMENTED EVIDENCE" (E.G. LINK TO A DOCUMENT OR WEBSITE OR CHART)—OR TO ME, YOUR "CLAIM" IS JUST "BS"; NOT A "FACT".
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM